Statement from President Joe Biden on Action to Lower Insulin Costs

Health & Medical Care, Press Release | March 3 2023

Eli Lilly & Co., a pharmaceutical company that produces insulin, has announced that it will cap out-of-pocket costs for insulin at $35 a month for all Americans, regardless of their insurance status. This move comes after President Joe Biden urged drugmakers to lower insulin prices as part of his healthcare agenda.

(Read More)